Pet diabetes care devices sales will grow through 2036, led by insulin delivery devices at a 56.0% share of the product segment in 2026. The market is expected to reach USD 2.7 billion in 2026 and USD 4.9 billion by 2036, creating an absolute opportunity of USD 2.2 billion.